Location History:
- Rastra, IN (2013)
- Parbhani, IN (2015)
Company Filing History:
Years Active: 2013-2015
Title: Mallesham Bejugam: Innovator in Pharmaceutical Compounds
Introduction
Mallesham Bejugam is a notable inventor based in Parbhani, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target critical biological pathways.
Latest Patents
Mallesham Bejugam holds three patents, with his latest innovations focusing on substituted amino-pyrimidine derivatives. These patents describe novel substituted quinazoline and pyrido-pyrimidine compounds, along with their pharmaceutically acceptable salts, prodrugs, and solvates. The compounds are designed to co-regulate PI3K and/or mTOR activity, which is crucial for treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. These compounds are particularly effective as dual PI3K/mTOR inhibitors and can be used to treat various diseases, including cancer, characterized by inflammation or abnormal cellular proliferation.
Career Highlights
Throughout his career, Mallesham has worked with reputable companies such as Asana Biosciences, LLC and Endo Pharmaceuticals Inc. His work has significantly advanced the understanding and treatment of diseases linked to the PI3K/AKT/mTOR pathway.
Collaborations
Mallesham has collaborated with esteemed colleagues, including Roger Astbury Smith and Srinivas Nanduri, contributing to the advancement of pharmaceutical research and development.
Conclusion
Mallesham Bejugam's innovative work in developing novel pharmaceutical compounds has the potential to make a significant impact in the treatment of various diseases. His contributions to the field exemplify the importance of research and innovation in healthcare.